Genesis Global Group
Genesis Drug Discovery & Development
GD3

You will now be redirected to the GD3 website

Genesis Drug Discovery & Development is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.

Learn more about GD3
Search

Disease Modeling

Biomarker Core

Biomarkers play an important role in preclinical research by enabling researchers to understand the biological processes that are changing either in the disease model or in response to the experimental therapeutic. They can help inform studies evaluating safety and efficacy to make the drug development process more efficient and targeted. GD3 scientists can deploy multiple techniques and capabilities to determine the underlying effect of your test article in disease models, including:

  • Multiplex cytokine, chemokine and hormone analysis
  • qPCR and RT-qPCR
  • Multicolor flow cytometry